Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premier P4P demo extension

This article was originally published in The Gray Sheet

Executive Summary

CMS approves a three-year extension to the Premier hospital pay-for-performance demonstration project, Premier announces Feb. 22. The hospital group recently reported positive second-year results from the program, which awards Medicare incentive payments to the highest performing hospitals based on certain quality-of-care measures (1"The Gray Sheet" Feb. 5, 2007, p. 19). The extension provides flexibility to include additional mortality and patient safety measures and clinical conditions, and will evaluate new incentive models that pay hospitals that reach a quality threshold or show the most improvement. CMS has signaled an interest in expanding the P4P demonstration to hospitals beyond the Premier network on a voluntary basis...

You may also be interested in...



Premier Program Addresses Validation Of Best Practices And Products

A new program from the group purchasing organization Premier purports to give health care product and service suppliers a chance to prove the value of their offerings in an independent evaluation

Pay-For-Performance Looks Good In Demo, CMS Says

CMS is touting new data that moves officials closer to determining how a value-based hospital purchasing program for Medicare might work

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel